Designing population pharmacokinetic studies: Performance of mixed designsFADIRAN, E. O; JONES, C. D; ETTE, E. I et al.European journal of drug metabolism and pharmacokinetics. 2000, Vol 25, Num 3-4, pp 231-239, issn 0378-7966Article

Population pharmacokinetics : A regulatory perspectiveHE SUN; FADIRAN, E. O; HOSSAIN, M et al.Clinical pharmacokinetics. 1999, Vol 37, Num 1, pp 41-58, issn 0312-5963Article

The process of knowledge discovery from large pharmacokinetic data setsETTE, Ene I; WILLIAMS, Paul; HE SUN et al.Journal of clinical pharmacology. 2001, Vol 41, Num 1, pp 25-34, issn 0091-2700Article

The interaction of gallium with biological systemsHAYES, R. L.International journal of nuclear medicine & biology. 1983, Vol 10, Num 4, pp 257-261, issn 0047-0740Article

Doit-on éviter l'association clopidogrel-inhibiteur de la pompe à protons ? = Should the combinatiotion clopidogrel-proton pump inhibitor be avoided?DEPLANQUE, Dominique.Neurologie.com. 2010, Vol 2, Num 5, pp 112-114, issn 2100-9511, 3 p.Article

Pharmacokinetic/pharmacodynamic relationships: Basic conceptsTROCONIZ, I. F.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, pp 125-126, issn 0379-0355, 2 p., SUPDConference Paper

Understanding the time course of pharmacological effect: a PKPD approachWRIGHT, Daniel F. B; WINTER, Helen R; DUFFULL, Stephen B et al.British journal of clinical pharmacology. 2011, Vol 71, Num 6, pp 815-823, issn 0306-5251, 9 p.Article

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Pharmacocinétique comparée des aminosides utilisés en dose unique journalière = Once daily aminoglycoside pharmacokinecticsPETITJEAN, O; PREVOT, M; LORTHOLARY, O et al.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 22-36, issn 0399-077X, NSConference Paper

Pharmacologie d'un nouvel agent anesthésique le propofol (Diprivan^®) = Pharmacology of a new anaesthetic drug propofol (diprivan*)HARMEY, J.-L; DEYDIER, P.-Y.Agressologie (Paris). 1987, Vol 28, Num 10, pp 1019-1023, issn 0002-1148Conference Paper

Intrathecal morphine and heroin in humans: six-hour drug levels in spinal fluid and plasmaKOTOB, H. I. M; HAND, C. W; MOORE, R. A et al.Anesthesia and analgesia. 1986, Vol 65, Num 7, pp 718-722, issn 0003-2999Article

Distribution of trichloroethylene between plasma and erythrocytes in whole blood from fasting subjectsDAVIES, D. D; DOUGLAS, R. B; LING, S et al.British Journal of Anaesthesia. 1986, Vol 58, Num 12, pp 1440-1442, issn 0007-0912Article

Pharmacologie et indications de la kétamine = Pharmacology and indications of ketamineCONSTANTIN, P.Médecine et hygiène. 1986, Vol 44, Num 1674, pp 2790-2792, issn 0025-6749Article

Some properties of Plackett and Hewlett's model for the joint action of drugsUNKELBACH, H. D; WOLF, T.Biometrical journal. 1986, Vol 28, Num 6, pp 741-746, issn 0323-3847Article

Radioactive metal complexes with affinity for tumors. II: Biodistribution of radioactivity in cellular and subcellular fractions of tumor tissuesKARUBE, Y; IWAMOTO, K; MIURA, J et al.Chemical and pharmaceutical bulletin. 1989, Vol 37, Num 7, pp 1874-1876, issn 0009-2363, 3 p.Article

Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patientsMAITRE, P. O; VOZEH, S; HEYKANTS, J et al.Anesthesiology (Philadelphia). 1987, Vol 66, Num 1, pp 3-12, issn 0003-3022Article

Pharmacodynamics and pharmacokinetics of recombinant hirudin via four non-parenteral routesLIU, Yu; LU, Wan-liang; ZHANG, Xuan et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 3, pp 423-430, issn 0196-9781, 8 p.Article

Distribution of topically administered drugs to the posterior segment of rabbit eye : IV meeting of the inter-regional group Abruzzo, Lazio, Molise, Toscana, Umbria of the Italian Society of Pharmacology, Pisa, March 11, 1991ROMANELLI, L; MORRONE, L. A; GUGLIELMOTTI, A et al.Pharmacological research. 1992, Vol 25, pp 39-40, issn 1043-6618, SUP1Conference Paper

Pharmacokinetics of toremifeneANTTILA, M; VALAVAARA, R; KIVINEN, S et al.Journal of steroid biochemistry. 1990, Vol 36, Num 3, pp 249-252, issn 0022-4731, 4 p.Conference Paper

Biokinetics and metabolism of radiogalliumKRIEGEL, H.Nuclear-Medizin. 1984, Vol 23, Num 2, pp 53-57, issn 0029-5566Article

Dose-independent pharmacokinetics of fentanylMURPHY, M. R; HUG, C. C. JR; MCCLAIN, D. A et al.Anesthesiology (Philadelphia). 1983, Vol 59, Num 6, pp 537-540, issn 0003-3022Article

The clinical pharmacology of chlorambucil and prednimustineNEWELL, D. R; CALVERT, A. H; HARRAP, K. R et al.British journal of clinical pharmacology. 1983, Vol 16, Num 6, pp 762-763, issn 0306-5251Article

Bayesian analysis of population PK/PD models: General concepts and softwareLUNN, David J; BEST, Nicky; THOMAS, Andrew et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2002, Vol 29, Num 3, pp 271-307, issn 1567-567X, 37 p.Article

Expanding clinical applications of population pharmacodynamic modellingMINTO, C; SCHNIDER, T.British journal of clinical pharmacology. 1998, Vol 46, Num 4, pp 321-333, issn 0306-5251Conference Paper

Etude clinique, bactériologique et pharmacocinétique de l'amikacine en dose unique journalière en oncologie pédiatrique = Clinical bacteriological and pharmacokinetic study of once daily amikacin in children with solid tumorBOUFFET, E; FUHRùANN, C; FRAPPAZ, D et al.Médecine et maladies infectieuses. 1993, Vol 23, Num SEP, pp 55-59, issn 0399-077X, NSConference Paper